CKS2 was reported to be overexpressed in cholangiocarcinoma and stimulate the aggressiveness of cholangiocarcinoma by modulating cell cycle progression and mitochondrial caspase-dependent apoptosis [15]. This evidence concerns the gene CKS2 and cholangiocarcinoma.